Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT03944057 |
| Consolidated Lead Sponsor | Antengene |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | COMPLETED |
| Registered Enrollment | 82 participants (ACTUAL) |
| Registered Start Date | 2019-09-02 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Peking University Third Hospital | Beijing, China | Open Hospital Dossier -> |
| Henan Cancer Hospital | Zhengzhou, China | Open Hospital Dossier -> |
| The First Affiliated Hospital Of Soochow University | Suzhou, China | Open Hospital Dossier -> |
| The First Affiliated Hospital of Nanchang University | Nanchang, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.